A phase 2 randomised, open-label trial of maintenance of weight loss with alternate-weekly incretin medication dosing (ACTRN12625000609459)

Pilot WLM

This trial is Currently recruiting
Registration number ACTRN12625000609459

Program & service

This trial is being run with the Specialty Medicine service, and as part of the Endocrine & Diabetes program.

Trial phase

Phase 2

Trial participation type

This trial has been designed for the Clinical Research of a Drug.

Principle investigator

Associate Professor Priya Sumithran

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.